Caisse Des Depots ET Consignations acquired a new position in Alignment Healthcare, Inc. (NASDAQ:ALHC - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund acquired 199,391 shares of the company's stock, valued at approximately $2,243,000. Caisse Des Depots ET Consignations owned 0.10% of Alignment Healthcare at the end of the most recent reporting period.
Several other institutional investors have also added to or reduced their stakes in the stock. Rhumbline Advisers grew its holdings in Alignment Healthcare by 2.2% during the 4th quarter. Rhumbline Advisers now owns 135,704 shares of the company's stock worth $1,527,000 after acquiring an additional 2,937 shares during the period. R Squared Ltd acquired a new stake in Alignment Healthcare during the fourth quarter worth approximately $55,000. SG Americas Securities LLC increased its holdings in Alignment Healthcare by 11.7% in the fourth quarter. SG Americas Securities LLC now owns 49,272 shares of the company's stock worth $554,000 after purchasing an additional 5,163 shares in the last quarter. Charles Schwab Investment Management Inc. increased its holdings in Alignment Healthcare by 1.0% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 847,974 shares of the company's stock worth $9,540,000 after purchasing an additional 8,279 shares in the last quarter. Finally, Ballentine Partners LLC acquired a new position in Alignment Healthcare in the fourth quarter valued at approximately $121,000. 86.19% of the stock is currently owned by institutional investors.
Insider Buying and Selling
In other news, insider Robert L. Scavo sold 2,864 shares of the business's stock in a transaction that occurred on Thursday, March 27th. The stock was sold at an average price of $17.89, for a total value of $51,236.96. Following the transaction, the insider now owns 702,953 shares in the company, valued at $12,575,829.17. The trade was a 0.41 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO John E. Kao sold 90,000 shares of the company's stock in a transaction that occurred on Monday, January 13th. The shares were sold at an average price of $13.06, for a total value of $1,175,400.00. Following the completion of the transaction, the chief executive officer now directly owns 2,273,100 shares of the company's stock, valued at approximately $29,686,686. This represents a 3.81 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 1,956,855 shares of company stock worth $30,128,862. 6.60% of the stock is owned by insiders.
Alignment Healthcare Stock Down 0.4 %
NASDAQ:ALHC traded down $0.08 during trading hours on Tuesday, hitting $18.54. 1,400,024 shares of the company traded hands, compared to its average volume of 1,500,295. Alignment Healthcare, Inc. has a one year low of $4.46 and a one year high of $18.92. The company has a quick ratio of 1.60, a current ratio of 1.60 and a debt-to-equity ratio of 1.82. The company has a market cap of $3.56 billion, a PE ratio of -24.01 and a beta of 1.49. The firm's 50-day simple moving average is $15.36 and its 200-day simple moving average is $13.06.
Analysts Set New Price Targets
Several research firms have recently weighed in on ALHC. Stephens reiterated an "overweight" rating and issued a $17.00 price objective on shares of Alignment Healthcare in a research note on Monday, February 24th. William Blair reiterated an "outperform" rating on shares of Alignment Healthcare in a report on Friday, February 28th. Barclays increased their price objective on shares of Alignment Healthcare from $8.00 to $9.00 and gave the stock an "underweight" rating in a research report on Friday, February 28th. Stifel Nicolaus boosted their target price on Alignment Healthcare from $16.00 to $18.00 and gave the company a "buy" rating in a research report on Friday, February 28th. Finally, Bank of America increased their price target on Alignment Healthcare from $15.50 to $18.50 and gave the stock a "buy" rating in a report on Tuesday, March 4th. One analyst has rated the stock with a sell rating, three have assigned a hold rating, seven have assigned a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $14.83.
Check Out Our Latest Analysis on Alignment Healthcare
Alignment Healthcare Company Profile
(
Free Report)
Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.
Featured Articles
Before you consider Alignment Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Alignment Healthcare wasn't on the list.
While Alignment Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
